HE
Cybin Inc. Common Stock (HELP)
NASDAQ·Healthcare·Biotechnology
$5.18
-4.07%
Mkt Cap $269.43M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 16, 2026 | — | — | — | -$0.76 | -$0.99 | -30.53% | — | — |
| Q1 2026 Feb 13, 2026 | — | — | — | -$0.53 | -$0.72 | -35.85% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.74 | -$1.39 | -87.84% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.96 | -$1.10 | -14.72% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$0.98 | -$2.86 | -190.85% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.97 | -$0.12 | +88.02% | — | — |
| Q1 2024 Mar 31, 2024 | — | — | — | — | -$0.17 | — | — | — |
| Q1 2024 Feb 14, 2024 | — | — | — | -$1.22 | -$0.24 | +80.45% | — | — |
| Q4 2023 Nov 15, 2023 | — | — | — | — | -$0.05 | — | — | — |
| Q3 2023 Aug 14, 2023 | — | — | — | — | -$0.06 | — | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | — | -$0.07 | — | — | — |
| Q1 2023 Feb 14, 2023 | — | — | — | — | -$0.06 | — | — | — |
| Q4 2022 Nov 14, 2022 | — | — | — | — | -$0.06 | — | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | — | -$0.07 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.10 | — | — | — |
| Q1 2022 Feb 10, 2022 | — | — | — | — | -$0.10 | — | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | — | -$0.11 | — | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$0.09 | — | — | — |
| Q1 2021 Mar 31, 2021 | — | -$138 | — | — | -$0.09 | — | — | — |
| Q4 2020 Dec 31, 2020 | — | — | — | — | -$0.10 | — | — | — |